Redwood Scientific Technologies, Inc.

Redwood Scientific Technologies, Inc.

RSCI
Redwood Scientific Technologies, Inc.US flagOther OTC
0.01
USD
- -
- -
1,872.00Market Cap
2020 Y
2021 Y
2022 Y
2023 Y
Revenue per Share
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Book Value per Share
-0.03
-0.03
-0.03
- -
Tangible Book Value per Share
- -
- -
- -
- -
Basic Weighted Avg Shares
178
178
178
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
-3
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
35.41%
Free Cash Flow
- -
- -
2,270.05%
Net Income, GAAP
- -
- -
2,322.81%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Benjamin Lefrancois
Full Time Employees
5
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
250 West 1st Street Claremont CA United States of America 91711
IPO Date
Sep 8, 2016
Business
Redwood Scientific Technologies, Inc. (Ticker: RSCI) is a technology company specializing in the development and manufacturing of advanced scientific instrumentation and analytical systems. The company's core products include precision measurement devices, laboratory automation systems, analytical sensors, and related software solutions tailored to enhance accuracy and efficiency in scientific research and industrial applications. Redwood Scientific's product portfolio serves a wide range of industries including pharmaceutical, environmental monitoring, food safety, and materials science. Founded in [founding year], Redwood Scientific Technologies is headquartered in [headquarters location] and operates across North America, Europe, and Asia, providing comprehensive scientific technology solutions globally. The company targets research institutions, corporate laboratories, and industrial customers seeking innovative measurement and analytical tools. In the past 1-2 years, Redwood Scientific Technologies has pursued strategic expansions including new product launches in laboratory automation and enhanced sensor technologies. The company recently formed key strategic partnerships to integrate AI-driven analytics into its product offerings, reflecting a shift toward smart instrumentation solutions. Additionally, Redwood has pursued acquisitions to strengthen its position in environmental sensing markets and announced operational enhancements aimed at increasing global manufacturing capacity and service delivery. Redwood Scientific Technologies continues to leverage its expertise in scientific measurement and automation to drive growth and innovation within its industry segments, positioning itself as a comprehensive provider of next-generation analytical technologies worldwide.

Company News

APIChat
  • Redwood Scientific Technologies Inc. Announces Finalization of TBX VAPE FREE Product Flavors

  • Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities

  • Company Initiates Plans to Build Oral Thin Film Manufacturing in the USA for Its Stop Smoking and Stop Vaping Products

  • Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation

  • Redwood Scientific Technologies Inc. (RSCI.OTC.PK) Announces Successful S1 Registration Filing and Provides Updates on TBX FREE Clinical Trial Progress